COVID-19 Antibody Responses In Cystic Fibrosis
Recruiting
- Conditions
- COVID-19Cystic Fibrosis
- Registration Number
- NCT06274840
- Lead Sponsor
- Pilar Azevedo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Inclusion Criteria:<br><br> - Consenting people with cystic fibrosis of any age, genotype, transplant status and<br> disease severity<br><br>Exclusion Criteria:<br><br> - Refusal to give informed consent<br><br> - Contraindication to venepuncture
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SARS-COV-2 seroprevalence;Association of SARS-CoV-2 seropositivity, clinical symptoms and clinical outcomes in pwCF;Longitudinal comparison of the detection
- Secondary Outcome Measures
Name Time Method